D.E. Shaw & Co’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-621,786
| Closed | -$32.6M | – | 4325 |
|
|
2020
Q3 | $32.6M | Buy |
621,786
+15,032
| +2% | +$622K | 0.03% | 585 |
|
|
2020
Q2 | $20.2M | Sell |
606,754
-11,267
| -2% | -$359K | 0.02% | 770 |
|
|
2020
Q1 | $16.8M | Sell |
618,021
-1,017,812
| -62% | -$28.3M | 0.03% | 723 |
|
|
2019
Q4 | $32.3M | Sell |
1,635,833
-190,498
| -10% | -$3.05M | 0.04% | 580 |
|
|
2019
Q3 | $23.7M | Sell |
1,826,331
-88,363
| -5% | -$1.07M | 0.03% | 698 |
|
|
2019
Q2 | $23.8M | Sell |
1,914,694
-234,155
| -11% | -$3.11M | 0.03% | 665 |
|
|
2019
Q1 | $31.2M | Sell |
2,148,849
-449,793
| -17% | -$5.74M | 0.04% | 526 |
|
|
2018
Q4 | $28.7M | Buy |
2,598,642
+628,870
| +32% | +$8.75M | 0.04% | 547 |
|
|
2018
Q3 | $51.8M | Sell |
1,969,772
-274,537
| -12% | -$7.42M | 0.06% | 388 |
|
|
2018
Q2 | $45.9M | Buy |
2,244,309
+196,932
| +10% | +$4.23M | 0.06% | 393 |
|
|
2018
Q1 | $37.2M | Buy |
2,047,377
+303,611
| +17% | +$5.06M | 0.05% | 433 |
|
|
2017
Q4 | $24.3M | Buy |
1,743,766
+273,495
| +19% | +$3.7M | 0.03% | 591 |
|
|
2017
Q3 | $27.2M | Sell |
1,470,271
-135,523
| -8% | -$2.27M | 0.04% | 499 |
|
|
2017
Q2 | $27.1M | Sell |
1,605,794
-45,232
| -3% | -$688K | 0.04% | 480 |
|
|
2017
Q1 | $22M | Sell |
1,651,026
-164,569
| -9% | -$2.58M | 0.04% | 528 |
|
|
2016
Q4 | $27.3M | Buy |
1,815,595
+72,075
| +4% | +$952K | 0.05% | 500 |
|
|
2016
Q3 | $20.4M | Sell |
1,743,520
-9,374
| -0.5% | -$110K | 0.04% | 567 |
|
|
2016
Q2 | $18.9M | Buy |
1,752,894
+35,498
| +2% | +$366K | 0.03% | 569 |
|
|
2016
Q1 | $15.9M | Buy |
1,717,396
+138,900
| +9% | +$1.49M | 0.03% | 637 |
|
|
2015
Q4 | $23.4M | Sell |
1,578,496
-184,387
| -10% | -$3.09M | 0.03% | 578 |
|
|
2015
Q3 | $28.9M | Buy |
1,762,883
+269,561
| +18% | +$5.52M | 0.04% | 473 |
|
|
2015
Q2 | $34.1M | Buy |
1,493,322
+540,325
| +57% | +$10.8M | 0.05% | 436 |
|
|
2015
Q1 | $14.5M | Buy |
952,997
+180,556
| +23% | +$2.35M | 0.02% | 758 |
|
|
2014
Q4 | $9.3M | Buy |
772,441
+311,355
| +68% | +$3.56M | 0.01% | 1163 |
|
|
2014
Q3 | $5.23M | Sell |
461,086
-71,602
| -13% | -$817K | 0.01% | 1538 |
|
|
2014
Q2 | $6.43M | Buy |
532,688
+197,379
| +59% | +$2.33M | 0.01% | 1417 |
|
|
2014
Q1 | $3.91M | Buy |
335,309
+113,680
| +51% | +$1.93M | 0.01% | 1773 |
|
|
2013
Q4 | $3.92M | Sell |
221,629
-127,799
| -37% | -$2.15M | 0.01% | 1905 |
|
|
2013
Q3 | $5.03M | Buy |
349,428
+72,304
| +26% | +$1.11M | 0.01% | 1586 |
|
|
2013
Q2 | $4.17M | Buy |
+277,124
| New | +$3.66M | 0.01% | 1491 |
|
D.E. Shaw & Co's MNTA Position: Q4 2020 in Review
D.E. Shaw & Co sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 621,786 shares — an estimated $32.6M sold.
D.E. Shaw & Co first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $51.8M in Q3 2018. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- D.E. Shaw & Co reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- D.E. Shaw & Co sold 621,786 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $32.6M.
- D.E. Shaw & Co first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- D.E. Shaw & Co's Momenta Pharmaceuticals, Inc. position peaked at $51.8M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on D.E. Shaw & Co's 13F filing for Q4 2020, filed 16 Feb 2021.